Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease
<p><strong>Background</strong> Despite the substantial global burden of disease, rheumatic heart disease research receives little funding globally.</p> <p><strong>Methods</strong> Using data from the Global Burden of Disease Study and funding from the G-FIND...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2019
|
| Summary: | <p><strong>Background</strong> Despite the substantial global burden of disease, rheumatic heart disease research receives little funding globally.</p> <p><strong>Methods</strong> Using data from the Global Burden of Disease Study and funding from the G-FINDER database, we propose a novel logarithmic disability neglect index (DNI) to describe disease burden using disability-adjusted life years relative to funding for 16 major tropical diseases.</p> <p><strong>Results</strong> Across a range of diseases, rheumatic heart disease received the least funding relative to disease burden (DNI=3.83). Other diseases facing similar underfunding include cysticercosis (DNI=2.71) and soil-transmitted helminths (DNI=2.41).</p> <p><strong>Conclusions</strong> Rheumatic heart disease remains severely underfunded relative to disease burden.</p> |
|---|